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ABSTRACT
p21 is a well-established regulator of cell cycle pro-
gression. The role of p21 in DNA repair, however,
remains poorly characterized. Here, we describe a
critical role of p21 in a replication-coupled DNA
double-strand break (DSB) repair that is mechanis-
tically distinct from its cell cycle checkpoint
function. We demonstrate that p21-deficient cells
exhibit elevated chromatid-type aberrations,
including gaps and breaks, dicentrics and radial
formations, following exposure to several DSB-
inducing agents. p21/ cells also exhibit an
increased DNA damage-inducible DNA-PKCS S2056
phosphorylation, indicative of elevated non-
homologous DNA end joining. Concomitantly,
p21/ cells are defective in replication-coupled
homologous recombination (HR), exhibiting
decreased sister chromatid exchanges and HR-
dependent repair as determined using a crosslinked
GFP reporter assay. Importantly, we establish
that the DSB hypersensitivity of p21/ cells is
associated with increased cyclin-dependent kinase
(CDK)-dependent BRCA2 S3291 phosphorylation
and MRE11 nuclear foci formation and can be
rescued by inhibition of CDK or MRE11 nuclease
activity. Collectively, our results uncover a novel
mechanism by which p21 regulates the fidelity of
replication-coupled DSB repair and the mainten-
ance of chromosome stability distinct from its role
in the G1-S phase checkpoint.
INTRODUCTION
Of the various forms of DNA damage, the physical
severing of the sugar-phosphate backbone poses the
greatest threat to genome integrity. DNA double-strand
breaks (DSBs) can arise both exogenously, as a conse-
quence of exposure to ionizing radiation and certain
chemicals, and endogenously, as a result of collapsed rep-
lication forks or reactive oxygen species generated as a
by-product of normal metabolic processes. If inappropri-
ately repaired, DSBs have the potential to lead to cell
death or cellular transformation, the ﬁrst step in cancer
formation (1). The highly unstable karyotypes of the
majority of cancer cells are a testament to the pervasive
role of DSBs in the genesis of cancer.
To safeguard against the deleterious effects of DSBs,
prokaryotic and eukaryotic organisms have evolved two
highly regulated DSB repair pathways: homologous re-
combination (HR) and nonhomologous DNA end
joining (NHEJ). HR is an error-free pathway that
requires a homologous DNA sequence, either the sister
chromatid or the homologous chromosome, to function
as a template for re-synthesis of the severed DNA
strand. In humans, the principal effector proteins of HR
are homologs of the Saccharomyces cerevisiae RAD52
epistasis group (2). Of this group, the RAD51 protein
catalyzes the central step of strand capture and invasion
of the homologous DNA template (3). In contrast, NHEJ
does not require a homologous DNA sequence and often
re-ligates broken DNA ends with disregard for previous
contiguity. Thus, NHEJ is often error prone and muta-
genic. The principal effector proteins of NHEJ include
KU70, KU80, DNA-PKCS, DNA ligase IV and XRCC4
(4). Despite the critical importance of accurate DSB repair
for the prevention of cellular transformation and cancer,
our understanding of the factors that determine how
DSBs are repaired is incomplete. The cell cycle stage is
one factor known to have a strong bearing on DSB repair.
The p21Cip1/Waf1 protein is a member of a family of
cyclin-dependent kinase (CDK) inhibitors and is a major
regulator of cell cycle progression (5). To our knowledge,
no studies have systematically addressed the role of p21 in
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DSB repair. In this study, we have examined the role of
p21 in the cellular response to the DSB-inducing agents
mitomycin C (MMC), a DNA crosslinking agent, and
camptothecin (CPT) and etoposide (VP-16), topoisomer-
ase I and II poisons. We demonstrate that p21 plays a
major role in the regulation of replication-coupled DSB
repair that is mechanistically distinct from its role in the
G1-S checkpoint. Both human and murine p21/ cells
are hypersensitive to the clastogenic effects of MMC,
CPT and VP-16. Elevated chromatid-type aberrations
and DNA-PKCS pS2056 nuclear foci formation indicate
the increased activation of NHEJ in the absence of p21.
Concomitantly, DNA replication-coupled HR, as assessed
by measuring the frequency of sister chromatid exchanges
(SCEs) and the repair of a crosslinked GFP reporter sub-
strate, is reduced in the absence of p21. Furthermore, we
demonstrate that p21/ cells exhibit increased MRE11
nuclear foci and CDK-mediated BRCA2 S3291 phosphor-
ylation. Importantly, we establish that the DSB hypersen-
sitivity of p21/ cells can be rescued by both the
inhibition of CDK activity and MRE11 nuclease
activity. Collectively, our results strongly suggest that
p21 plays a central role in the coordination of early
steps of replication-coupled DSB repair and promotes
error-free HR.
MATERIALS AND METHODS
Cells and cell culture conditions
HCT116 wild-type, p21/ and p53/ cells (6,7) were
grown in McCoy’s 5A medium. B6-129/Sv p21+/+ and
p21/ mouse embryonic ﬁbroblasts (MEFs) and HeLa
cells were grown in Dulbecco’s Modiﬁed Eagle’s
Medium. All growth media was supplemented with 12%
v/v fetal bovine serum, L-glutamine and penicillin/
streptomycin.
Chromosome breakage analysis
Cells were incubated in the absence or presence of DNA-
damaging agents for 16 h. Before harvesting, cells were
treated with 0.1 mg/ml Colcemid (Gibco/Invitrogen) for
2 h. Cell pellets were incubated in 0.075M KCl at 37C
for 18min, followed by ﬁxation in Carnoy’s ﬁxative (3:1
methanol:glacial acetic acid) with multiple changes. Cells
were dropped onto chilled slides and air-dried before
staining with 2.5% w/v Giemsa solution (Sigma).
Metaphases were analyzed using a Zeiss AxioImager.A1
upright epiﬂuorescent microscope with AxioVision LE 4.6
image acquisition software.
siRNA experiments
HeLa cells were plated in six-well dishes at a density of
200 000 cells per well and transfected the following day
with p21-speciﬁc (sip21) or control, non-targeting
siRNA (siControl [siCtrl]) using Lipofectamine 2000
(Invitrogen). Fifty hours following transfection, cells
were incubated in the absence or presence of 50 and
100 nM MMC for 16 h and harvested for cytogenetic
analysis as described earlier. The following sense and
anti-sense siRNA sequences were used: sip21 (Qiagen)
50-GACCAUGUGGACCUGUCACTT-30 and 50-GUG
ACAGGUCCACAUGGUCTT-30 and non-targeting
siCtrl (Applied Biosystems/Ambion) 50-UAACGACGC
GACGUAATT-30 and 50-UUACGUCGUCGCGUCGU
UATT-30.
Sister chromatid exchange analysis
Cells were incubated for two cell cycles in the presence of
12 mM bromodeoxyuridine (Sigma) and incubated in the
absence or presence of DNA-damaging agents for one cell
cycle before harvest. Metaphase chromosome spreads
were prepared as described earlier. Slides were allowed
to air dry for 48 h, stained with 10 mg/ml Hoechst 33528
(Sigma) and then irradiated with 120 mJ/cm2 UV-C irradi-
ation for 10min using a XL-1000 Spectrolinker UV
Crosslinker (Spectronics Corporation). Slides were
stained with 3% w/v Giemsa in Sorensen’s buffer
(67mM Na2HPO4 2H2O, 67mM KH2PO4, pH 6.8) for
25min and analyzed as described earlier.
Replication-coupled, interstrand crosslink homologous
recombination assay
The assay involves transient transfection of the
TR-OriP-GFP HR reporter substrate with pCEP4
(Invitrogen, V044-50), allowing the expression of
Epstein-Barr nuclear antigen 1 (EBNA1) for replication
of TR-OriP-GFP, adapted from (8,9). Before transfection,
triplexes were formed in vitro by incubating 10 mM of
triplex forming oligonucleotide (TFO) or psoralen-TFO
(pso-TFO) with 20 mg TR-OriP-GFP for 30min in 40 ml
TFO buffer (50mM HEPES, pH 7.2, 50mM NaCl,
0.5mM spermine and 10mM MgCl2). Triplex or control
DNA and 20 mg pCEP4 were added to 5 106 cells in
800 ml Opti-MEM (Gibco) in a 0.4 cm gap cuvette
(Bio-Rad) and electroporated by pulsing at 250V,
950 mF. After electroporation, cells were placed in a
10-cm tissue culture dish with tissue culture media and
incubated at 37C. After 1 h, the media was replaced
with 1ml phosphate-buffered saline (PBS), and then cells
were irradiated with ultraviolet radiation A (UV-A) (0.15 J
cm2 at 365 nm) in a Stratalinker (Stratagene) with the lid
removed. After irradiation, 10ml of fresh tissue culture
media was added to the cells. GFP+ cells were quantiﬁed
by ﬂow cytometry 48 h after transfection using a Becton
Dickinson FACScan.
Immunoblotting and antibodies
For immunoblotting analysis, cell suspensions were
washed in ice-cold PBS and lysed in 1% v/v Triton
X-100, 0.5% w/v sodium deoxycholate, 0.1% w/v
sodium dodecyl sulphate in PBS supplemented with
protease and phosphatase inhibitors (Sigma). Proteins
were resolved on NuPAGE 3–8% w/v Tris-Acetate or
4–12% w/v Bis-Tris gels (Invitrogen) and transferred to
polyvinylidene diﬂuoride membranes. Membranes were
immunoblotted with mouse monoclonal antisera against
BRCA2 (OP95; Calbiochem/EMD Chemicals),
DNA-PKCS (Ab-2/25-4; Thermo Scientiﬁc), gH2AX
(JBW301; Millipore) and a-tubulin (Ab-2; LabVision),
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and rabbit polyclonal antisera BRCA2 pS3291 (10),
DNA-PKCS pS2056 (ab18192; Abcam), p21 (N-20;
Santa Cruz Biotechnology) and MRE11 (NB100-142;
Novus Biologicals).
Immunoﬂuorescence microscopy
For immunoﬂuorescence (IF) analyses, cells were seeded
in four-well tissue culture slides (BD Biosciences) and
treated with MMC for 16 hr. Cells were ﬁxed in 4% w/v
paraformaldehyde in PBS for 20min at 4C, followed by
permeabilization for 5min in 0.3% v/v Triton X-100 in
PBS. Fixed cells were incubated with primary antibodies
in 5% v/v goat serum, 0.1% v/v NP40, in PBS for 1 hr,
washed three times with PBS and then incubated with
alexaﬂuor 488-conjugated anti-mouse or anti-rabbit sec-
ondary antibodies (Invitrogen) for 45min. Cells were
then counterstained and mounted in vectashield plus
406-diamidine-2-phenylindole dihydrochloride (Vector
Laboratories) and visualized using a Zeiss AxioImager.A1
upright epiﬂuorescent microscope with AxioVision LE 4.6
image acquisition software. Primary antibodies used for
IF were anti-53BP1 (H300; Santa Cruz Biotechnology),
anti-BRCA1 (D9; Santa Cruz Biotechnology), anti-CtIP
(a kind gift from Richard Baer, Columbia University) and
anti-MRE11 (PC388; Calbiochem/EMD Chemicals).
RESULTS
Functional requirement for p21 in the cellular response to
the DNA crosslinking agent mitomycin C
We recently demonstrated that p21 is required for the
activation of the Fanconi anemia (FA) pathway: p21
promotes DNA damage-inducible FANCD2 and FANCI
monoubiquitination via transcriptional regulation of the
USP1 deubiquitinating enzyme (11). Therein, we also
reported that HCT116 p21/ cells exhibit elevated levels
of MMC-induced chromosome aberrations, compared
with p21+/+ cells. In this study, we sought to expand on
these observations and to uncover the molecular basis of
this phenotype. To examine the role of p21 in the mainten-
ance of chromosome stability in a non-transformed cell
model, we exposed B6-129/Sv p21+/+ and p21/ primary
MEFs to MMC and examined metaphase chromosomes
for the presence of chromosome and chromatid aberra-
tions. Similar to that previously observed for HCT116
p21/ cells (11), p21/ MEFs were more susceptible to
the clastogenic effects of MMC (Figure 1A–C). For
example, a >2-fold increase in the average number of
chromosome gaps and breaks was observed for the p21/
 MEFs, compared with the p21+/+ MEFs, at both con-
centrations of MMC examined (P< 0.01, in both cases)
(Figure 1A). Furthermore, a 12-fold increase in
complex chromosome aberrations was observed for
25 nM MMC-treated p21/ MEFs, compared with the
p21+/+ MEFs (P< 0.01) (Figure 1B). These complex
chromosome aberrations included Robertsonian-like
metacentric chromosomes as well as arrangements
involving multiple chromosomes (Figure 1C). Using an al-
ternative approach, depletion of p21 in HeLa cells using
siRNA also sensitized cells to the clastogenic effects of
MMC; a 2-fold increased frequency of chromosome
gaps and breaks was observed for p21-depleted cells
compared with cells transfected with a control,
non-targeting siRNA (p< 0.01) (Figure 1D and E).
Similarly, a 4-fold increased frequency of MMC-
inducible complex chromosome aberrations was observed
for p21-depleted cells (P< 0.05) (Figure 1F). Importantly,
transient transfection of HCT116 p21/ cells with the p21
cDNA rescued their MMC hypersensitivity, resulting in a
signiﬁcant reduction in MMC-inducible chromosome gaps
and breaks and complex chromosome aberrations
(Figure 1G–I). Furthermore, spectral karyotyping
(SKY)/multicolor ﬂuorescence in situ hybridization (M-
FISH) analysis of metaphase chromosomes from
MMC-treated p21/ cells conﬁrmed the presence of il-
legitimate chromatid-type interchanges resulting in the for-
mation of chromosome structural aberrations including
unbalanced chromosome translocations (Supplementary
Figure S1). Taken together these ﬁndings clearly establish
an important function for p21 in the maintenance of
chromosome stability following exposure to the DNA
interstrand crosslinking agent MMC.
p21/ cells are hypersensitive to the clastogenic effects
of type I and II topoisomerase poisons
The high frequency of dicentric chromosomes and
complex chromosome aberrations observed in MMC-
treated p21-deﬁcient cells suggested a more general
defect in DSB repair. DSBs have been demonstrated to
arise during the DNA replication-coupled repair of
DNA interstrand crosslinks (ICLs) (12,13). To determine
whether p21 plays a role in the cellular response to other
agents known to induce the formation of DSBs, p21+/+
and p21/ cells were exposed to the type I and II topo-
isomerase poisons CPT and VP-16, respectively, and
metaphase chromosomes were analyzed for the presence
of chromosome and chromatid aberrations. Similar to
that observed for MMC, markedly elevated levels of
chromatid-type aberrations were observed for
VP-16-treated p21/ cells, compared with VP-16-treated
p21+/+cells (Figure 2A–C). For example, a 6-fold increase
in chromatid gaps and breaks (p< 0.001) was observed for
the p21/ cells, compared with p21+/+ cells, after
exposure to 0.2mM VP-16 (Figure 2A). Importantly, di-
centric chromosomes were frequently observed for the
VP-16-treated p21/ cells and were never observed for
p21+/+ cells (Figure 2B). In addition, a 5-fold increase
in complex chromosome aberrations (P=0.005),
including radial chromosome formations, was observed
for the p21/ cells, compared with p21+/+cells, following
exposure to 0.2 mMVP-16 (Figure 2C). We also monitored
gH2AX nuclear foci formation following treatment with
VP-16. We observed an increased spontaneous gH2AX
nuclear foci formation in the p21/ cells. In addition,
persistently elevated levels of gH2AX nuclear foci were
observed for p21/ cells up to 7 h following exposure to
VP-16, at which point levels had returned to normal in
wild-type cells (Supplementary Figure S2). Moreover,
similar to that observed for MMC and VP-16, elevated
8350 Nucleic Acids Research, 2012, Vol. 40, No. 17
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levels of chromatid-type aberrations were observed for
p21/ cells treated with CPT (Figure 2D–F). For
example, we detected an 11-fold increase (P< 0.05) in
complex chromosome aberrations in 0.8 nM CPT-treated
p21/ cells, compared with the p21+/+ cells (Figure 2F).
Taken together, our results demonstrate that p21-deﬁcient
cells exhibit pronounced chromosome instability following
exposure to several DSB-inducing agents, most likely as a
result of defective DSB repair.
The role of p21 in the maintenance of chromosome
stability is independent of the G1-S checkpoint
We next sought to determine whether the increased DNA
damage-inducible chromosome instability of the p21/
cells was a consequence of a defective G1-S phase check-
point or altered cell cycle progression in general. Thus, we
performed a series of experiments with both p21/ and
p53/ cells, reasoning that if the effect of p21 was merely
related to altered cell cycle dynamics, then the same
phenotype would be observed for p53/ cells (7).
However, this is not what we observed. Instead, p21/
cells were markedly more sensitive to the clastogenic
effects of MMC than p53/ cells (Figure 3A–C). For
example, a 3-fold increase (P< 0.001) in MMC-
induced gaps and breaks was observed for p21/ cells,
compared with p53/ cells, following exposure to 20 nM
MMC (Figure 3A). Under the same conditions, an
11-fold increase (P< 0.01) in dicentric chromosome for-
mations was observed for p21/ cells, compared with
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Figure 1. Functional requirement for p21 in the cellular response to the DNA crosslinking agent mitomycin C. (A–C) p21+/+ and p21/ MEFs were
incubated in the absence or presence of 25 and 50 nM MMC for 18 h, and the numbers of chromosome gaps and breaks (A), and complex
chromosome aberrations (B), including dicentric chromosomes and radial formations, were scored. At least 50 metaphases were scored per treatment.
(C) Representative chromosome aberrations detected in p21/ MEFs. Arrows point to radial chromosomes; arrowheads point to chromatid fusions.
(D–F) HeLa cells were transfected with control, non-targeting (siCtrl) and p21 (sip21) siRNAs. Fifty-four hours post-transfection, cells were
incubated in the absence or presence of 50 and 100 nM MMC for 16 h. (D) Whole-cell lysates were prepared, and resolved proteins were
immunoblotted with anti-p21 and anti-a-tubulin antibodies. The asterisk denotes a non-speciﬁc band. (E and F) Metaphase spreads were
prepared, and chromosome gaps and breaks (E) and complex chromosome aberrations (F) were scored. (G–I) HCT116 p21/ cells were transiently
transfected with pLenti6.2-p21 or pLenti6.2-lacZ and treated with 0, 10 and 20 nM MMC for 16 h. (G) Whole-cell lysates were prepared, and
resolved proteins were immunoblotted with anti-p21 and anti-a-tubulin antibodies. The asterisk denotes a non-speciﬁc band. (H and I) Metaphase
spreads were prepared, and chromosome gaps and breaks (H) and complex chromosome aberrations (I), including dicentric chromosomes and radial
formations, were scored. At least 80 metaphases were scored per treatment. Error bars represent the standard errors of the means from independent
experiments. *P< 0.05; **P< 0.01; ***P< 0.001.
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p53/ cells (Figure 3B). Similar results were obtained for
wild-type, p21/ and p53/ cells following treatment
with CPT (results not shown).
In an alternative approach, we synchronized wild-type,
p21/ and p53/ cells in early S-phase by double-
thymidine block, incubated cells in the absence or
presence of MMC and examined metaphase chromosome
damage. The cell cycle stage proﬁles of wild-type, p21/
and p53/ cells were very similar following
double-thymidine arrest (Supplementary Figure S3A).
Although the p21/ cells appeared to progress to G2-M
at a faster rate than wild-type and p53/ cells, cell
cycle stage proﬁles and mitotic indices following
MMC exposure were indistinguishable (Supplementary
Figure S3B). Double-thymidine arrest, by itself, resulted
in a measurable increase in chromosome aberrations for
all three cell types (Figure 3D–F). However, in the case of
gaps and breaks and dicentric chromosome formations,
the p21/ cells exhibited the greatest degree of sensitivity
(Figure 3D and E). Furthermore, following exposure of
synchronized cells to MMC, a pronounced increase in
gaps and breaks, dicentric chromosome formations and
complex chromosome aberrations were observed for the
p21/ cells compared with wild-type and p53/ cells
(Figure 3D–F). For example, a 6-fold increase
(P< 0.05) in dicentric chromosome formations was
observed for the p21/ cells compared with p53/
cells, following synchronization and treatment with
10 nMMMC (Figure 3E). p53/ cells express appreciable
levels of p21 protein, albeit at a reduced level compared
with wild-type cells (Figure 3G). Collectively, these results
strongly suggest that the role of p21 in the maintenance of
chromosome stability is independent of G1-S-phase tran-
sition and not an indirect consequence of altered cell cycle
progression.
Elevated nonhomologous DNA end-joining activity in
p21/ cells
Our observations of increased MMC-, VP-16- and
CPT-inducible chromatid-type interchanges in the
absence of p21 suggested the increased activity of the typ-
ically error-prone NHEJ DSB repair pathway. To test this
hypothesis, we examined the recruitment of DNA-PKCS
to discrete nuclear foci in the p21+/+ and p21/ cells,
using an antibody raised speciﬁcally against the
DNA-PKCS protein phosphorylated on S2056 (14,15).
An increased DNA-PKCS pS2056 nuclear foci formation
was observed in the p21/ cells both in the absence and
presence of MMC (Figure 4A and B). For example, a
2-fold increased DNA-PKCS pS2056 nuclear foci forma-
tion was observed in the p21/ cells, compared with the
p21+/+ cells, both spontaneously and following exposure
to 20 nM MMC (P< 0.0001) (Figure 4A and B). These IF
ﬁndings were corroborated by immunoblotting whole-cell
lysates prepared from untreated and MMC-treated p21+/+
and p21/ cells, with the same DNA-PKCS pS2056
antibody. Substantially increased protein levels of
DNA-PKCS pS2056 were observed in both untreated
and MMC-treated p21/ cells, compared with the
p21+/+ cells (Figure 4C). In addition, in a pulse-chase
experiment, we observed persistently elevated levels of
both gH2AX and DNA-PKCS pS2056 nuclear foci in
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p21/ cells up to 7 h following exposure to MMC, at
which point levels had begun to decrease in wild-type
cells (P< 0.001 in both cases) (Supplementary Figure
S4A and B). These ﬁndings demonstrate elevated levels
of unrepaired DSBs and increased NHEJ activity in the
absence of p21 following treatment with MMC, suggesting
that p21 may negatively regulate this typically error-prone
DSB repair pathway.
p21 is required for DNA replication-coupled homologous
recombination
Next, to determine whether p21 plays a role in the regula-
tion of HR DSB repair, we measured the frequencies of
both spontaneous and DNA damage-inducible SCEs in
p21+/+ and p21/ cells. SCEs are a cytogenetically
visible manifestation of HR between sister chromatids
(16). No differences in the spontaneous frequency of SCE
between p21+/+ and p21/ cells were observed, with an
average of approximately four SCEs per metaphase for
both cell types (Figure 5A–C). However, we observed
signiﬁcant differences in the frequencies of both MMC-
and CPT-inducible SCEs between the p21+/+and p21/
cells (Figure 5A and B). For example, a 2-fold increase
(P< 0.0001) in the numbers of SCEs per metaphase
chromosome was observed for p21+/+ cells, compared
with p21/ cells, following exposure to MMC and CPT
(Figure 5A and B). However, in direct contrast, no
differences in the frequencies of VP-16-inducible SCEs
were observed between the p21+/+ and p21/ cells
(Figure 5C).
To directly test the role of p21 in DNA
replication-coupled ICL HR repair we utilized the
recently developed TR-OriP-GFP assay, which measures
HR repair of a psoralen-UVA crosslinked triplex
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oligonucleotide (9). The TR-OriP-GFP substrate contains
the Epstein-Barr virus (EBV) origin of replication,
allowing it to replicate in the presence of the EBV
nuclear antigen EBNA1 (Figure 5D). A marked reduction
in replication-dependent ICL-induced HR repair was
observed in the absence of p21 (P< 0.001), compared
with wild-type p21 cells (Figure 5E). p21 did not affect
DNA replication per se, as transfection of an OriP
vector containing an intact GFP gene led to a similar
increase in GFP+ cells in the absence or presence of p21
(data not shown).
To determine whether defective replication-coupled HR
repair in the p21/ cells was a result of a defect in the
localization of the RAD51 recombinase, we examined
RAD51 nuclear foci formation in the p21+/+ and p21/
cells. Although we observed a >2-fold increase
(P< 0.0001) in the percentage of p21/ nuclei exhibiting
RAD51 nuclear foci in the absence of DNA damage, no
differences in the percentage of nuclei exhibiting RAD51
nuclear foci were observed between p21+/+ and p21/
cells up to 48 h following exposure to MMC
(Supplementary Figure S5).
Elevated MRE11 nuclease activity contributes to the
increased chromosome instability of p21/ cells
To gain mechanistic insight into the origins of increased
NHEJ and decreased HR activity in p21-deﬁcient cells, we
next examined the recruitment of several DNA repair
proteins known to act early in the DSB response. First,
we examined the recruitment of the MRE11 nuclease, a
protein known to play a very early role in the sensing and
nucleolytic processing of DSBs and in the choice of HR
and NHEJ pathways (17). To our surprise, we observed a
marked elevation of MRE11 nuclear foci formation in
the p21/ cells. In the absence of MMC, a 3-fold
increase (P < 0.001) in the percentage of nuclei exhibiting
MRE11 foci was observed for the p21/ cells, compared
with both wild-type (p53+/+/p21+/+) and p53/ cells
(Figure 6A and B). A dose-dependent increase in
MRE11 nuclear foci formation was observed for both
the wild-type and the p53/ cells following exposure to
MMC. However, under the same conditions, no appre-
ciable change in the percentage of p21/ nuclei harboring
MRE11 foci was detected (Figure 6A and B). Differences
in the percentage of nuclei containing MRE11 foci could
not be attributed to changes in MRE11 protein levels, as
measured by immunoblotting analysis (Figure 6C). We
also examined BRCA1 and CtIP nuclear foci formation
in these cells. BRCA1 and CtIP also act early in the DNA
damage response and, together with MRE11, are thought
to regulate the extent of nucleolytic processing of DSBs
(18–21). Similar to that observed for MRE11, albeit to a
lesser degree, we observed increased basal levels of
BRCA1 and CtIP nuclear foci formation in p21/ cells
(Supplementary Figure S6A and B). However, in contrast
to that observed for MRE11, BRCA1 and CtIP, no dif-
ferences in the percentage nuclei positive for 53BP1 foci
formation were observed between p21+/+and p21/ cells,
both in the absence or presence of MMC (Supplementary
Figure S6C).
To determine whether increased MRE11 nuclear foci
formation might contribute to the increased sensitivity
of the p21/ cells to the clastogenic effects of MMC,
we incubated p21/ cells in the absence and presence of
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both MMC and mirin, a chemical inhibitor of MRE11
nuclease activity (22). Treatment of p21/ cells with
mirin had no discernible effect on spontaneous chromo-
some instability (Figure 6D–F). However, co-treatment of
p21/ cells with MMC and mirin resulted in a
pronounced decrease in susceptibility to the clastogenic
effects of MMC (Figure 6D–F). For example, we
observed a 2-fold reduction (P< 0.05) in gaps and
breaks in cells co-treated with MMC and mirin,
compared with cells treated with MMC alone
(Figure 6D). In addition, under the same conditions, we
observed a 8-fold reduction in dicentric chromosomes
(P< 0.05 for 10 mM mirin) (Figure 6E). Under these con-
ditions, we did not observe a signiﬁcant difference in
percent survival between cells incubated in the absence
or presence of MMC and mirin (Supplementary Figure
S7). Collectively, these results suggest that in the absence
of p21, inappropriate MRE11 nuclease activity may
promote error-prone DSB repair activity and increased
chromosome instability.
Increased CDK-mediated BRCA2 S3291 phosphorylation
in p21/ cells
Previous studies have demonstrated that BRCA2 S3291
phosphorylation leads to the destabilization of RAD51
nucleoprotein ﬁlaments (23). Misregulation of this
process has been shown to lead to inappropriate
MRE11-dependent DNA replication fork instability
(24). Therefore, we next examined the levels of both un-
modiﬁed BRCA2 and BRCA2 phosphorylated on S3291,
a CDK-dependent post-translational modiﬁcation (10), in
p21+/+ and p21/ cells. Total BRCA2 levels were uni-
formly reduced in the absence of p21 (Figure 7A, lanes
4–6). In addition, we observed increased BRCA2 S3291
phosphorylation both in the absence and presence of
MMC. For example, following exposure to 40 nM
MMC, we detected a 2-fold increased BRCA2
pS3291:BRCA2 ratio in the absence of p21 (Figure 7A
and B), suggesting that increased CDK-mediated
BRCA2 phosphorylation might also contribute to the
chromosome instability phenotype of p21/ cells. To de-
termine whether this was indeed true, we next incubated
p21/ cells in the absence and presence of both MMC
and roscovitine, a cell-permeable reversible CDK inhibitor
and again scored metaphase chromosome aberrations.
Importantly, co-treatment of p21/ cells with MMC
and roscovitine led to a signiﬁcant reduction in the
frequencies of both chromosome gaps and breaks and
complex chromosome aberrations. For example, we
observed a 5-fold reduction (P< 0.01) in complex
chromosome aberrations in p21/ cells co-treated with
20 nM MMC and 3 mM roscovitine, compared with
p21/ cells treated with MMC alone (Figure 7D).
Under these conditions, no appreciable differences in cell
cycle stage distribution, mitotic index or percent survival
were observed for p21/ cells incubated in the absence or
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presence of MMC and roscovitine (Supplementary Figure
S8A–C). Collectively, our results strongly suggest that
increased CDK-mediated BRCA2 S3291 phosphorylation
promotes chromosome instability in MMC-treated p21/
cells.
DISCUSSION
In this study, we have established that p21 plays a novel
role in the promotion of error-free replication-coupled
DSB repair. This role is mechanistically distinct from its
well-known function in the G1-S-phase checkpoint. A
colorectal carcinoma cell line harboring a homozygous
p21 deletion, p21-null primary MEFs and cells depleted
of p21 using siRNA, all display hypersensitivity to the
clastogenic effects of the DNA crosslinking agent MMC.
Importantly, hypersensitivity of the p21/ cells to MMC
was rescued by transient re-expression of p21. In addition,
we show that p21/ cells are hypersensitive to the
clastogenic effects of the topoisomerase I and II poisons
CPT and VP-16, respectively. All three DNA-damaging
agents are potent inducers of DSBs, albeit via different
mechanisms, discussed further below. In support of our
ﬁndings, a recent report has described the physical accu-
mulation of p21 at laser-irradiated sites and co-localizing
with gH2AX (25). In addition to chromosome gaps and
breaks, p21/ cells demonstrate a markedly increased fre-
quency of DNA damage-inducible chromatid-type
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aberrations, including dicentric chromosomes and
complex chromatid interchanges. These aberrations most
likely arise as a consequence of increased NHEJ.
Consistent with this hypothesis, we observed elevated
and persistent levels of phosphorylated DNA-PKCS
S2056 in p21/ cells, a marker of NHEJ (15), suggesting
the inappropriate engagement of DNA-PKCS with DSB
ends. In addition, we observed persistent DNA
damage-inducible gH2AX nuclear foci formation in the
absence of p21 strongly suggesting an outright defect in
DSB repair. Furthermore, we have established an import-
ant role for p21 in replication-coupled HR: p21-deﬁcient
cells display reduced DNA damage-inducible SCEs and
are defective for replication-dependent HR repair of a
site-speciﬁc ICL, similar to that recently described for
FA patient cells (9). Thus, we have established that, in
addition to its role in the G1-S phase checkpoint, p21 is
a negative regulator of error-prone NHEJ and a positive
regulator of error-free HR. Similarly, an important role
for p21 in the negative regulation of the error-prone
translesion DNA synthesis pathway has been established
(26).
Using several approaches, we have also ﬁrmly estab-
lished that this newly discovered function for p21 in
DSB repair is mechanistically distinct from its role in
G1- to S-phase progression, nor is it an indirect conse-
quence of altered cell cycle progression in general. First,
we demonstrate that asynchronous p21/ cells are
markedly more sensitive to MMC than similarly derived
asynchronous p53/ cells. The G1-S-phase checkpoint is
similarly abrogated in both cell lines (7), arguing that a
defective G1-S-phase checkpoint is not the primary cause
of the pronounced sensitivity of the p21/ cells to
DSB-inducing agents. Second, we show that cell
cycle-synchronized p21/ cells display markedly greater
sensitivity to MMC than synchronized wild-type and
p53/ cells, arguing that this phenotype is not a general
consequence of altered cell cycle progression. For the
latter experiment, it is important to note that the cell
cycle stage distributions and mitotic indices of
MMC-treated p21/ and p53/ cells were very similar,
indicating that differences in the rate of S and G2 progres-
sion do not underlie the observed phenotype. Instead, we
demonstrate that p21/ cells exhibit elevated levels of
MRE11 nuclear foci formation, even in the absence of
exposure to DNA-damaging agents. This phenotype was
not observed for the p53/ cells. We also demonstrate
that treatment of p21/ cells with mirin, a chemical in-
hibitor of MRE11 nuclease activity, rescues the MMC
hypersensitivity of these cells, strongly suggesting that in-
appropriate MRE11 nuclease activity promotes chromo-
some instability in the absence of p21. Several recent
studies have described important roles for MRE11 in
NHEJ (27–29). However, the inappropriate use of
NHEJ can lead to genome rearrangements and chromo-
some instability, consistent with our observations.
MRE11 may act alone or in concert with other nucleases
such as CtIP and EXO1 (30–32). Our ﬁndings of increased
spontaneous CtIP nuclear foci formation in the p21/
cells suggest a cooperative role for CtIP. However, the
contribution of EXO1 to this phenotype remains to be
determined.
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Recently, it has been established that the BRCA2
protein prevents nascent DNA strand degradation on
DNA replication fork stalling by stabilizing RAD51 nu-
cleoprotein ﬁlaments on single-stranded DNA (ssDNA)
(24,33). In the absence of BRCA2, or RAD51, inadvertent
MRE11 nuclease activity promotes fork degradation and
chromosome instability (24,33). BRCA2 is subjected to
CDK-mediated phosphorylation on S3291 (10). S3291
phosphorylation blocks the binding of RAD51 oligomers
with the carboxy-terminus of BRCA2, leading to the de-
stabilization of RAD51 nucleoprotein ﬁlaments (10). On
exposure to DNA-damaging agents CDK-mediated
BRCA2 S3291 phosphorylation is decreased, resulting in
stimulation of RAD51 binding to the carboxy-terminus of
BRCA2, and increased HR activity (10). Our results
suggest that p21 plays a key role in the coordination of
this process via the inhibition of CDK activity (see
Figure 8). In the absence of p21, most likely as a conse-
quence of unrestricted CDK activity, both spontaneous
and DNA damage-inducible BRCA2 S3291 phosphoryl-
ation are elevated. We hypothesize that this leads to the
continuous disassembly of RAD51 nucleoprotein ﬁla-
ments, facilitating inappropriate MRE11 nuclease
activity. Consistent with this hypothesis, we demonstrate
that the MMC-hypersensitivity of p21/ cells can be
rescued by the inhibition of CDK activity or MRE11
nuclease activity. Although we detected an increase in
spontaneous RAD51 nuclear foci formation in the
absence of p21, we did not observe differences in the for-
mation or disappearance of RAD51 nuclear foci between
p21+/+ and p21/ cells following exposure to MMC.
RAD51 nucleoprotein loading onto ssDNA is mediated
by the BRC repeats of BRCA2 and is thus unlikely to
be affected by BRCA2 S3291 phosphorylation (34–36).
Furthermore, standard epiﬂuorescence microscopy
methods may not be sufﬁciently sensitive to detect rapid
RAD51 turnover. BRCA2 S3291 phosphorylation has
also been suggested to lead to BRCA2 proteolysis
(10,37), consistent with our observation of decreased
overall levels of BRCA2 in the absence of p21. It is also
important to note that although we did observe increased
spontaneous gH2AX and DNA-PKCS pS2056 nuclear foci
formation in the absence of p21, indicative of increased
DSBs, we did not detect spontaneous metaphase chromo-
some aberrations in these cells. However, the presence of
submicroscopic chromosome aberrations including small
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Figure 8. Proposed model for the role of p21 in replication-coupled DNA double-strand break repair. Following exposure to DNA-damaging agents
that block DNA replication fork progression, p21 physically binds to, and inhibits, CDK, thereby preventing phosphorylation of BRCA2 on S3291.
RAD51 nucleoprotein ﬁlaments assemble on ssDNA and are stabilized through interaction with the unphosphorylated carboxy-terminus of BRCA2,
thereby promoting HR repair. In the absence of p21, unrestricted CDK activity leads to the constitutive phosphorylation of BRCA2 on S3291. S3291
phosphorylation precludes binding of RAD51 to the carboxy-terminus of BRCA2, resulting in destabilization of RAD51 nucleoprotein ﬁlaments.
Deprotected ssDNA now becomes susceptible to opportunistic and inadvertent MRE11 nuclease activity, leading to increased error-prone NHEJ and
chromosome instability.
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interstitial deletions or duplications, which would not be
readily detectable using the conventional cytogenetic
analyses used in this study, remains a distinct possibility.
Here, we also make the observation that p21 is required
for HR between sister chromatids following exposure to
MMC and CPT, but not VP-16, providing further mech-
anistic insight into p21’s role in the maintenance of
chromosome stability. VP-16 forms a ternary complex
with topoisomerase II and DNA and prevents re-ligation
of the severed DNA duplex, thereby generating two-ended
DSBs irrespective of cell cycle stage (38). In contrast,
MMC-induced ICLs are converted to one-ended DSBs
only on encounter with a DNA replication fork (12).
Similarly, CPT forms a ternary complex with topoisomer-
ase I and DNA and prevents re-ligation of the single-
nicked DNA strand, again giving rise to a one-ended
DSB on encounter with the replication fork. Our results
suggest that p21 preferentially promotes one-ended
DSB-induced sister chromatid recombination at stalled
DNA replication forks, yet may be dispensable for
two-ended DSB HR mechanisms such as synthesis-
dependent strand annealing.
Taken together, our ﬁndings represent an important ad-
vancement in our understanding of the molecular mech-
anisms regulating the repair of DSBs, particularly upon
DNA replication fork arrest. In a capacity mechanistically
distinct from its role in the G1-S-phase checkpoint,
p21-mediated inhibition of CDK activity facilitates the
interaction between RAD51 and the carboxy-terminus of
BRCA2, thereby promoting conservative HR DNA
repair. In contrast, the absence of p21 renders stalled
DNA replication forks susceptible to opportunistic and
inappropriate MRE11-mediated nucleolytic attack,
driving potentially error-prone repair pathways such as
NHEJ, ultimately leading to increased genome instability.
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